Literature DB >> 20405312

Does polyamine oxidase activity influence the oxidative metabolism of children who suffer of diabetes mellitus?

G Bjelakovic1, S Beninati, B Bjelakovic, D Sokolovic, T Jevtovic, I Stojanovic, S Rossi, C Tabolacci, G Kocić, D Pavlovic, Lj Saranac, S Zivic.   

Abstract

Diabetes mellitus is a metabolic disease characterized by inadequate secretion of insulin. Polyamine oxidase (PAO), a FAD-containing enzyme is involved in the biodegradation of Sp and Spd, catalyzing the oxidative deamination of Sp and Spd, resulting in production of ammonia (NH(3)), corresponding amino aldehydes and H(2)O(2). Malondialdehyde (MDA) and acrolein (CH2=CHCHO), potentially toxic agents, which induce oxidative stress in mammalian cells, are then spontaneously formed from aminoaldehydes. The main signs of oxidative stress in diabetic children were the values of HbA1c and MDA levels. Polyamines have an insulin-like action. Antiglycation property of spermine and spermidine has been recently confirmed. There are no data in the literature about plasma polyamine oxidase (PAO) activities in children with type 1 diabetes. The idea of this study was to evaluate the polyamine metabolism through the estimation of polyamine oxidase activity. We have study children with newly diagnosed type 1 diabetes mellitus (n = 35, age group of 5-16 years, as well as age-matched healthy control subjects (n = 25). The biochemical investigations were done on diabetic children who have the pathological values of glucose (9.11-17.33 mmol/l) and glycosylated Hb (7.57-14.49% HbA(1c)). The children in the control group have referent values of glucose and glycated hemoglobin (4.11-5.84 mmol/L and HbA(1c) 4.22-6.81% of the total Hb. Glucose levels in blood plasma and glycosylated hemoglobin in erythrocythes hemolysates (HbA1c) were measured by using standard laboratory methods. PAO activity in venous blood plasma and the amount of malondialdehyde (MDA) were measured by the spectrophotometric methods. PAO activity, glycemia, HbA1c and MDA were significantly increased in diabetic children compared to the control subjects. PAO activity in children with type 1 diabetes mellitus was very high. The findings of higher blood HbA(1C) and MDA levels confirm the presence of oxidant stress in children with type 1 diabetes mellitus and demonstrate that PAO activity may participate in these circumstances.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20405312     DOI: 10.1007/s11010-010-0439-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  43 in total

1.  Tumor attenuation by combined heparan sulfate and polyamine depletion.

Authors:  Mattias Belting; Lubor Borsig; Mark M Fuster; Jillian R Brown; Lo Persson; Lars-Ake Fransson; Jeffrey D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Heparan sulphate/heparin glycosaminoglycans with strong affinity for the growth-promoter spermine have high antiproliferative activity.

Authors:  M Belting; B Havsmark; M Jönsson; S Persson; L A Fransson
Journal:  Glycobiology       Date:  1996-03       Impact factor: 4.313

3.  Effects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus.

Authors:  Wan Ting Hsu; Li Yu Tsai; Shu Kai Lin; Jen Kuei Hsiao; Bai Hsiun Chen
Journal:  Ann Clin Lab Sci       Date:  2006       Impact factor: 1.256

4.  Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion.

Authors:  Slavoljub Vujcic; Ping Liang; Paula Diegelman; Debora L Kramer; Carl W Porter
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

5.  Effects of secretagogues on insulin biosynthesis and secretion in polyamine-depleted pancreatic beta-cells.

Authors:  A Sjöholm
Journal:  Am J Physiol       Date:  1996-04

6.  Enzymic assay for spermine and spermidine.

Authors:  U Bachrach; B Reches
Journal:  Anal Biochem       Date:  1966-10       Impact factor: 3.365

7.  Oxidation of spermidine and spermine in rat liver: purification and properties of polyamine oxidase.

Authors:  E Hölttä
Journal:  Biochemistry       Date:  1977-01-11       Impact factor: 3.162

Review 8.  Genetic manipulation of polyamine catabolism in rodents.

Authors:  Juhani Jänne; Leena Alhonen; Marko Pietilä; Tuomo A Keinänen; Anne Uimari; Mervi T Hyvönen; Eija Pirinen; Aki Järvinen
Journal:  J Biochem       Date:  2006-02       Impact factor: 3.387

9.  Diamine oxidase and polyamine oxidase activities in normal and transformed cells.

Authors:  G Quash; T Keolouangkhot; L Gazzolo; H Ripoll; S Saez
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

10.  Oxidative degradation of polyamines in rat pancreatic hypertrophy.

Authors:  E Rabellotti; A Sessa; P Tunici; S Bardocz; G Grant; A Pusztai; A Perin
Journal:  Biochim Biophys Acta       Date:  1998-04-28
View more
  6 in total

Review 1.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

Review 2.  Autoimmune diseases and polyamines.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

3.  Protective effects of polyamine depletion in mouse models of type 1 diabetes: implications for therapy.

Authors:  Sarah A Tersey; Stephanie C Colvin; Bernhard Maier; Raghavendra G Mirmira
Journal:  Amino Acids       Date:  2013-07-12       Impact factor: 3.520

Review 4.  Role of Polyamines and Hypusine in β Cells and Diabetes Pathogenesis.

Authors:  Abhishek Kulkarni; Cara M Anderson; Raghavendra G Mirmira; Sarah A Tersey
Journal:  Metabolites       Date:  2022-04-12

Review 5.  Acrolein: A Potential Mediator of Oxidative Damage in Diabetic Retinopathy.

Authors:  Moaddey Alfarhan; Eissa Jafari; S Priya Narayanan
Journal:  Biomolecules       Date:  2020-11-20

Review 6.  Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy.

Authors:  Tyler N Kambis; Hadassha M N Tofilau; Flobater I Gawargi; Surabhi Chandra; Paras K Mishra
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.